XML 172 R153.htm IDEA: XBRL DOCUMENT v3.24.0.1
QUARTERLY FINANCIAL DATA (UNAUDITED) - Quarterly Financial Results and Market for Company's Stock (Details) - USD ($)
 3 Months Ended 12 Months Ended
Nov. 01, 2023
Sep. 29, 2023
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Effect of Fourth Quarter Events [Line Items]                          
Net sales     $ 3,885,000,000 $ 3,708,000,000 $ 3,707,000,000 $ 3,513,000,000 $ 3,745,000,000 $ 3,609,000,000 $ 3,594,000,000 $ 3,558,000,000 $ 14,813,000,000 $ 14,506,000,000 $ 12,146,000,000
Gross margin     1,472,000,000 1,117,000,000 1,111,000,000 1,275,000,000 1,388,000,000 1,045,000,000 1,371,000,000 1,262,000,000 4,975,000,000 5,066,000,000 4,720,000,000
Income (loss) from continuing operations     73,000,000 51,000,000 (193,000,000) 0 144,000,000 (2,991,000,000) 185,000,000 8,000,000 (69,000,000) (2,654,000,000) 1,033,000,000
Income from discontinued operations, net of tax     173,000,000 2,460,000,000 54,000,000 45,000,000 41,000,000 57,000,000 70,000,000 65,000,000 2,732,000,000 233,000,000 262,000,000
Income (loss) from continuing operations     246,000,000 2,511,000,000 (139,000,000) 45,000,000 185,000,000 (2,934,000,000) 255,000,000 73,000,000 2,663,000,000 (2,421,000,000) 1,295,000,000
Net income (loss) attributable to Baxter stockholders     $ 245,000,000 $ 2,508,000,000 $ (141,000,000) $ 44,000,000 $ 181,000,000 $ (2,937,000,000) $ 252,000,000 $ 71,000,000 $ 2,656,000,000 $ (2,433,000,000) $ 1,284,000,000
Income (loss) from continuing operations per common share                          
Basic (in dollars per share)     $ 0.14 $ 0.09 $ (0.39) $ (0.00) $ 0.28 $ (5.94) $ 0.36 $ 0.01 $ (0.15) $ (5.29) $ 2.04
Diluted (in dollars per share)     0.14 0.09 (0.39) (0.00) 0.28 (5.94) 0.36 0.01 (0.15) (5.29) 2.01
Income from discontinued operations per common share                          
Basic (in dollars per share)     0.34 4.85 0.11 0.09 0.08 0.11 0.14 0.13 5.40 0.46 0.52
Diluted (in dollars per share)     0.34 4.83 0.11 0.09 0.08 0.11 0.14 0.13 5.40 0.46 0.52
Net Income (loss) per common share                          
Basic (in dollars per share)     0.48 4.95 (0.28) 0.09 0.36 (5.83) 0.50 0.14 5.25 (4.83) 2.56
Diluted (in dollars per share)     $ 0.48 $ 4.93 $ (0.28) $ 0.09 $ 0.36 $ (5.83) $ 0.50 $ 0.14 $ 5.25 $ (4.83) $ 2.53
Other long-lived asset impairments       $ 267,000,000             $ 470,000,000 $ 9,000,000 $ 11,000,000
Goodwill impairments $ 0                   $ 0 $ 2,812,000,000 $ 0
Hillrom | Trade Names                          
Net Income (loss) per common share                          
Impairment of indefinite-lived intangible asset               $ 332,000,000          
Hillrom | Surgical Solutions Reporting Unit                          
Net Income (loss) per common share                          
Goodwill impairments             $ 27,000,000 $ 2,790,000,000          
Manufacturing Facility                          
Net Income (loss) per common share                          
Other long-lived asset impairments         $ 243,000,000                
Discontinued Operations, Disposed of by Sale | BioPharma Solutions                          
Net Income (loss) per common share                          
Pre-tax gain on sale   $ 2,880,000,000